sleep apnea CC study
Overview of CPAP and Hypoglossal Nerve Stimulation
CPAP as First-Line Therapy:
Well-established but adherence issues (50% documented).
Increased interest in alternatives, notably hypoglossal nerve stimulation (FDA approved in 2014).
Sleep Apnea Classification
Positional Sleep Apnea:
Worse in supine position, AHI > 2x higher supine.
Affects 50-60% of obstructive sleep apnea patients.
Nonpositional Sleep Apnea:
No positional dependence.
Airway Physiology Differences:
Positional: Gravity-dependent; more airway collapse when supine.
Nonpositional: Generalized airway collapse, consistent regardless of position.
Study Objectives and Methodology
Primary Aim: Change in overall apnea-hypopnea index (AHI) post-implantation.
Secondary Aims: Changes in supine vs. non-supine AHI and sleep architecture, patient symptom evaluation via Epworth Sleepiness Scale (ESS).
Study Design: Retrospective observational study, 2022-March 2025.
Inclusion Criteria: Adults (18+), moderate-severe obstructive sleep apnea, CPAP intolerant, BMI < 32, prior drug-induced sleep endoscopy.
Exclusion Criteria: Histories of various medical conditions or prior hypoglossal nerve stimulation involvement.
Results Summary
Patients Analyzed: 30 (median age 69; 73% male; median BMI 28.9).
Total AHI Reduction: From 23.5 to 4.8 (significant).
Supine AHI Reduction: From 43.9 to 12.3 (significant).
REM Sleep AHI Reduction: From 33.5 to 7.1.
ESS Score Reduction: From 8 to 6 (significant).
Sleep Architecture: Stable except notable reduction in total sleep time in supine position.
Subgroup Analysis
Positional OSA Patients: Total number 18. AHI reduction from 22.6 to 4.5; supine AHI from 47.5 to 12.6. ESS reduction by 2 points.
Nonpositional OSA Patients: Total number 9. AHI reduction from 32 to 4.1; supine AHI from 34 to 11. ESS reduction by 3 points.
Key Findings:
Greater AHI reduction in non-supine AHI for nonpositional patients.
Subjective sleepiness improved more in nonpositional patients.
Conclusion
Hypoglossal nerve stimulation effectively treats patients intolerant to CPAP, with notable improvements across both positional and nonpositional classifications
Study provides insights for managing expectations for patients with positional sleep apnea.